Kayoko Sugawara

Saitama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Validation of the Baveno Endoscopy Avoidance Criteria in Japanese Patients With Chronic Liver Disease: A Real-World Cohort Study.

Validation of the Baveno Endoscopy Avoidance Criteria in Japanese Patients With Chronic Liver Disease: A Real-World Cohort Study.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 04, 2026

Clinical Outcomes of Gradual Corticosteroid Tapering for Immune Checkpoint Inhibitor-Induced Liver Injury.

Clinical Outcomes of Gradual Corticosteroid Tapering for Immune Checkpoint Inhibitor-Induced Liver Injury.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: May 24, 2026

Short-Term Clinical Effects After Switching From Zinc Acetate Hydrate to Zinc Histidine Hydrate in Patients With Chronic Liver Disease.

Short-Term Clinical Effects After Switching From Zinc Acetate Hydrate to Zinc Histidine Hydrate in Patients With Chronic Liver Disease.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: March 18, 2026

A case presenting with abdominal pain, jaundice, and anemia on a cold night

A case presenting with abdominal pain, jaundice, and anemia on a cold night

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: February 11, 2026

Rifaximin Use Is Associated With Prognosis and Recurrence Patterns in Spontaneous Bacterial Peritonitis: Exploratory Insights Into the Oral-Gut-Hepatic Axis.

Rifaximin Use Is Associated With Prognosis and Recurrence Patterns in Spontaneous Bacterial Peritonitis: Exploratory Insights Into the Oral-Gut-Hepatic Axis.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: November 26, 2025

A case of non-HIV pneumocystis pneumonia in a patient with cirrhosis-associated immune dysfunction.

A case of non-HIV pneumocystis pneumonia in a patient with cirrhosis-associated immune dysfunction.

Journal: Clinical journal of gastroenterology

Published: March 19, 2025

Hepatocellular Carcinoma Complicated by Fulminant Type 1 Diabetes Mellitus Shortly After Initiation of Durvalumab Plus Tremelimumab.

Hepatocellular Carcinoma Complicated by Fulminant Type 1 Diabetes Mellitus Shortly After Initiation of Durvalumab Plus Tremelimumab.

Journal: Internal medicine (Tokyo, Japan)

Published: December 25, 2024

Endoscopic management of primary sclerosing cholangitis.

Endoscopic management of primary sclerosing cholangitis.

Journal: Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society

Published: September 18, 2024

Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis.

Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis.

Journal: Journal of gastroenterology

Published: July 25, 2024

Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA.

Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: December 11, 2023

Usefulness of atezolizumab plus bevacizumab as second-line therapy for patients with unresectable hepatocellular carcinoma.

Usefulness of atezolizumab plus bevacizumab as second-line therapy for patients with unresectable hepatocellular carcinoma.

Journal: PloS one

Published: September 04, 2023

Significance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir.

Significance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 10, 2023

Showing 1-12 of 45

Last Updated: 09/26/2026